225 related articles for article (PubMed ID: 36282503)
1. Assessment of Cystatin C Level for Risk Stratification in Adults With Chronic Kidney Disease.
Lees JS; Rutherford E; Stevens KI; Chen DC; Scherzer R; Estrella MM; Sullivan MK; Ebert N; Mark PB; Shlipak MG
JAMA Netw Open; 2022 Oct; 5(10):e2238300. PubMed ID: 36282503
[TBL] [Abstract][Full Text] [Related]
2. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.
Chen DC; Shlipak MG; Scherzer R; Bauer SR; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
JAMA Netw Open; 2022 Feb; 5(2):e2148940. PubMed ID: 35175342
[TBL] [Abstract][Full Text] [Related]
3. Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study.
Husain SA; Willey JZ; Park Moon Y; Elkind MSV; Sacco RL; Wolf M; Cheung K; Wright CB; Mohan S
PLoS One; 2018; 13(11):e0206839. PubMed ID: 30427947
[TBL] [Abstract][Full Text] [Related]
4. Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality.
O'Seaghdha CM; Tin A; Yang Q; Katz R; Liu Y; Harris T; Astor B; Coresh J; Fox CS; Kao WH; Shlipak MG
Am J Kidney Dis; 2014 Jan; 63(1):16-22. PubMed ID: 23932088
[TBL] [Abstract][Full Text] [Related]
5. Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study.
Willey JZ; Moon YP; Husain SA; Elkind MSV; Sacco RL; Wolf M; Cheung K; Wright CB; Mohan S
PLoS One; 2020; 15(1):e0226509. PubMed ID: 31940363
[TBL] [Abstract][Full Text] [Related]
6. Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure.
Chen DC; Shlipak MG; Scherzer R; Bansal N; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
Am J Kidney Dis; 2022 Dec; 80(6):762-772.e1. PubMed ID: 35817274
[TBL] [Abstract][Full Text] [Related]
7. Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race.
Gutiérrez OM; Sang Y; Grams ME; Ballew SH; Surapaneni A; Matsushita K; Go AS; Shlipak MG; Inker LA; Eneanya ND; Crews DC; Powe NR; Levey AS; Coresh J;
JAMA; 2022 Jun; 327(23):2306-2316. PubMed ID: 35667006
[TBL] [Abstract][Full Text] [Related]
8. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.
Shardlow A; McIntyre NJ; Fraser SDS; Roderick P; Raftery J; Fluck RJ; McIntyre CW; Taal MW
PLoS Med; 2017 Oct; 14(10):e1002400. PubMed ID: 29016597
[TBL] [Abstract][Full Text] [Related]
9. Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S.
Tsai CW; Grams ME; Inker LA; Coresh J; Selvin E
Diabetes Care; 2014 Apr; 37(4):1002-8. PubMed ID: 24271191
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rates for predicting all-cause mortality in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry.
Ide H; Iwase M; Fujii H; Ohkuma T; Kaizu S; Jodai T; Kikuchi Y; Idewaki Y; Sumi A; Nakamura U; Kitazono T
Clin Exp Nephrol; 2017 Jun; 21(3):383-390. PubMed ID: 27339449
[TBL] [Abstract][Full Text] [Related]
11. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
Potok OA; Ix JH; Shlipak MG; Katz R; Hawfield AT; Rocco MV; Ambrosius WT; Cho ME; Pajewski NM; Rastogi A; Rifkin DE
Am J Kidney Dis; 2020 Dec; 76(6):765-774. PubMed ID: 32682697
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women.
Driver TH; Scherzer R; Peralta CA; Tien PC; Estrella MM; Parikh CR; Butch AW; Anastos K; Cohen MH; Nowicki M; Sharma A; Young MA; Abraham A; Shlipak MG
AIDS; 2013 Sep; 27(14):2291-9. PubMed ID: 23669156
[TBL] [Abstract][Full Text] [Related]
13. Cystatin C- and Creatinine-based Estimated GFR Differences: Prevalence and Predictors in the UK Biobank.
Chen DC; Lu K; Scherzer R; Lees JS; Rutherford E; Mark PB; Potok OA; Rifkin DE; Ix JH; Shlipak MG; Estrella MM
Kidney Med; 2024 Apr; 6(4):100796. PubMed ID: 38567244
[TBL] [Abstract][Full Text] [Related]
14. Medication-Related Adverse Events and Discordancies in Cystatin C-Based vs Serum Creatinine-Based Estimated Glomerular Filtration Rate in Patients With Cancer.
Hanna PE; Wang Q; Strohbehn IA; Moreno D; Harden D; Ouyang T; Katz-Agranov N; Seethapathy H; Reynolds KL; Gupta S; Leaf DE; Sise ME
JAMA Netw Open; 2023 Jul; 6(7):e2321715. PubMed ID: 37405775
[TBL] [Abstract][Full Text] [Related]
15. Discrepancies between Cystatin C-Based and Creatinine-Based eGFR.
Farrington DK; Surapaneni A; Matsushita K; Seegmiller JC; Coresh J; Grams ME
Clin J Am Soc Nephrol; 2023 Sep; 18(9):1143-1152. PubMed ID: 37339177
[TBL] [Abstract][Full Text] [Related]
16. Discordances Between Creatinine- and Cystatin C-Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice.
Carrero JJ; Fu EL; Sang Y; Ballew S; Evans M; Elinder CG; Barany P; Inker LA; Levey AS; Coresh J; Grams ME
Am J Kidney Dis; 2023 Nov; 82(5):534-542. PubMed ID: 37354936
[TBL] [Abstract][Full Text] [Related]
17. Modification of Association of Cystatin C With Kidney and Cardiovascular Outcomes by Obesity.
Chen DC; Scherzer R; Ix JH; Kramer HJ; Crews DC; Nadkarni G; Gutierrez O; Bullen AL; Ilori T; Garimella PS; Shlipak MG; Estrella MM
Am J Kidney Dis; 2024 Apr; 83(4):489-496.e1. PubMed ID: 37866793
[TBL] [Abstract][Full Text] [Related]
18. Differential Associations of Cystatin C Versus Creatinine-Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank.
Chen DC; Lees JS; Lu K; Scherzer R; Rutherford E; Mark PB; Kanaya AM; Shlipak MG; Estrella MM
J Am Heart Assoc; 2023 Feb; 12(3):e027079. PubMed ID: 36695320
[TBL] [Abstract][Full Text] [Related]
19. GFR estimated with creatinine rather than cystatin C is more reflective of the true risk of adverse outcomes with low GFR in kidney transplant recipients.
Keddis MT; Howard MR; Galapia L; Barreto EF; Zhang N; Butterfield RJ; Rule AD
Nephrol Dial Transplant; 2023 Jul; 38(8):1898-1906. PubMed ID: 36646435
[TBL] [Abstract][Full Text] [Related]
20. Association of Cystatin C Kidney Function Measures With Long-term Deficit-Accumulation Frailty Trajectories and Physical Function Decline.
Li C; Ma Y; Yang C; Hua R; Xie W; Zhang L
JAMA Netw Open; 2022 Sep; 5(9):e2234208. PubMed ID: 36178684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
